Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib in Combination With Azacitidine in Patients With Chronic Myelomonocytic Leukemia
NCT06159491Phase 2Recruiting
- Start
- Sep 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pacritinib in chronic myelomonocytic leukemia (CMML). Started Sep 2024; status: recruiting.
02
Drugs
pacritinib
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT06159491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06159491.